510(k) Market Clearance for FluChip-8G Influenza A+B Assay

InDevR receives 510(k) market clearance for the first influenza diagnostic assay capable of distinguishing between seasonal and non-seasonal influenza A subtypes

BOULDER, Colo., April 30, 2019 -- (Healthcare Sales & Marketing Network) -- InDevR Inc., a... Diagnostics, FDA InDevR, FluChip, Influenza

Source: HSMN NewsFeed - April 30, 2019 Category: Pharmaceuticals Source Type: news